| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 02/21/2007 | EP1355905B1 Pyrazole compounds useful as protein kinase inhibitors |
| 02/21/2007 | EP0968193B1 Phenylsulphonyl ureas, processes for their preparation and their use as herbicides and plant-growth regulators |
| 02/21/2007 | CN1918156A Isothiazole dioxides as cxc- and cc-chemokine receptor ligands |
| 02/21/2007 | CN1918155A Compounds and compositions as lxr modulators |
| 02/21/2007 | CN1918147A 1,2,3,4-tetrahydroisoquinoline derivatives, preparations thereof and uses thereof |
| 02/21/2007 | CN1918138A Thiadiazoles as cxc- and cc- chemokine receptor ligands |
| 02/21/2007 | CN1918131A Novel inhibitors of glutaminyl cyclase |
| 02/21/2007 | CN1917921A Calcitonin gene related peptide receptor antagonists |
| 02/21/2007 | CN1917881A Novel phenylalanine derivatives |
| 02/21/2007 | CN1917880A Pyrimidines with tie2 (tek) activity |
| 02/21/2007 | CN1917879A Pyrimidines with tie2 (tek) activity |
| 02/21/2007 | CN1915992A Sodium salts of 5-'4-'2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione |
| 02/21/2007 | CN1915991A Synthesis of indole thiazole compounds as ligands for the ah receptor |
| 02/20/2007 | US7179922 Chemical compounds |
| 02/20/2007 | US7179918 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 02/20/2007 | US7179912 Materials and methods to potentiate cancer treatment |
| 02/20/2007 | US7179896 Method of making PNA oligomers |
| 02/20/2007 | US7179827 Such as (S)-(4-(ethylamino)-2-((4-methylpiperidin-1-yl)methyl)thiazol-5-yl)(2-(methoxymethyl)pyrrolidin-1-yl)methanone; for treatment of neurological and psychiatric disorders/diseases, cancer, and disorders mediated by protein kinase inhibition |
| 02/20/2007 | US7179826 Antiproliferative agnets; antitumor agents; anticancer agents; cardiovascular disorders; central nervous system disorders; autoimmune diseases; antiinflammatory agents |
| 02/20/2007 | US7179825 Such as N-(2-benzotriazolyl)-N'-(4-(1-(1H-imidazol-1-yl)-2-ethylbutyl)phenyl) -thiourea; for treatment of cellular proliferation/differentiation disorders; keratinization; oncology; dermatology |
| 02/20/2007 | US7179823 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 02/20/2007 | US7179822 Hetero biaryl derivatives as matrix metalloproteinase inhibitors |
| 02/20/2007 | US7179815 For example, 3-[2(R)-{hydroxycarbonylpropyl-amino}-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methyl-pyrimidine-2,4(1H,3H)-dione; use in treating prostate cancer, benign prostatic hypertrophy, breast cancer and endometriosis |
| 02/20/2007 | US7179810 Phthalazinone-piperidino-derivatives as PDE4 inhibitors |
| 02/20/2007 | US7179808 Such as 3-[[4-(4-chlorophenyl)-2-thiazolyl]methoxy]-N-propyl-benzenemethanamine; nicotinamide adenine dinucleotide oxidase hydride donor inhibitors |
| 02/20/2007 | US7179804 Tachykinin receptor antagonists |
| 02/20/2007 | US7179802 reducing the risk of developing a condition selected from the group consisting of hypercholesterolemia, atherosclerosis, low HDL levels, high LDL levels, hyperlipidemia, hypertriglyceridemia and dyslipidemia |
| 02/20/2007 | CA2344574C Thyroid receptor ligands |
| 02/20/2007 | CA2186784C The use of carboxylic acid derivatives as drugs |
| 02/20/2007 | CA2180156C Self-assembled taxo-diperpenoid nanostructures |
| 02/20/2007 | CA2119745C Nonpeptidyl integrin inhibitors having specificity for gpiibiiia receptor |
| 02/20/2007 | CA2085192C Fungicidal derivatives of 2-imidazoline-5-ones and 2-imidazoline-5-thiones |
| 02/15/2007 | WO2007018956A2 Antidiabetic oxazolidinediones and thiazolidinediones |
| 02/15/2007 | WO2007018461A1 Novel benzothiazolone derivatives |
| 02/15/2007 | WO2007018325A1 N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof |
| 02/15/2007 | WO2007018319A1 Pyridylphenol compound and use thereof |
| 02/15/2007 | WO2007017728A2 Novel heterocyclic compounds |
| 02/15/2007 | WO2007017509A1 Compounds for the treatment of alzheimer's disease |
| 02/15/2007 | WO2007017507A1 Beta-secretase inhibitors for use in the treatment of alzheimer's disease |
| 02/15/2007 | WO2007017114A1 New substituted azathymidine derivatives and their use in the treatment of bacterial infectious diseases |
| 02/15/2007 | WO2007017096A1 Pyrazine derivatives useful as adenosine receptor antagonists |
| 02/15/2007 | WO2007017095A1 A process for the preparation of substituted phenyl ether compounds and rosiglitazone |
| 02/15/2007 | WO2007016979A2 NOVEL HETEROCYCLIC NF-κB INHIBITORS |
| 02/15/2007 | WO2006136829A3 Pyrazole derivatives and their use as pka and pkb modulators |
| 02/15/2007 | WO2006079504A3 Process for the manufacture of a precursor of vitamin b1 |
| 02/15/2007 | WO2005123703A8 Alkynyl derivatives as modulators of metabotropic glutamate receptors |
| 02/15/2007 | US20070037978 Amidating chloro-, methyl-, methoxy, ethyl- or ethoxy-substituted aniline with 2,3-dichloroacryloyl chloride, alkanoate salt and inorganic base to form an N-phenyl-2-chloro-3,3-dimethoxypropionamide (that is also claimed), which is reacted with thiourea to form a N-phenyl-2-aminothiazol-5-ylcarboxamide |
| 02/15/2007 | US20070037888 4-(Pyrazol-3-ylamino) pyrimidine derivatives for use in the treatment of cancer |
| 02/15/2007 | US20070037863 Dipeptide phenyl ethers |
| 02/15/2007 | US20070037862 inhibitors of polo-like kinases; (4,4-Dimethyl-4,5-dihydro-oxazol-2-yl)-[3-ethyl-4-oxo-5-[1-[3-(2-pyrrolidin-1-yl-ethyl)-phenylamino]-meth-(E/Z)-ylidene]-thiazolidin-(2-(E or Z))-ylidene]-acetonitrile; cancer, auto-immune diseases, cardiovascular diseases |
| 02/15/2007 | US20070037859 Substituted Thiazolidinedione Derivative, Process for Its Preparation and Its Pharmaceutical Use |
| 02/15/2007 | US20070037858 Hexyl carboxanilides and their use for controlling undesirable micro-organisms |
| 02/15/2007 | US20070037850 Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
| 02/15/2007 | US20070037836 Melanin concentrating hormone; obesity and related disorders, anxiety, or depression; trans-4-Bromo-N-{4-[(4-dimethylamino-quinazolin-2-ylamino)-methyl]-cyclohexylmethyl}-2-trifluoromethoxy-benzenesulfonamide |
| 02/15/2007 | US20070037819 Treating chronic neuropathic or inflammatory pain; [(1-methyl-1H-pyrrol-2-yl)methyl][[1-[(4-pyrazin-2-ylpiperazin-1-yl)acetyl]-4-[3-trifluoromethyl)phenyl]piperid-4-yl]methyl]amine |
| 02/15/2007 | US20070037808 Anti-inflammatory medicaments |
| 02/15/2007 | US20070037801 Novel indoles are cannabinoid receptor ligands |
| 02/15/2007 | US20070037796 e.g. 7-Phenyl-isoquinoline-5-sulfonic acid {2-[3 -(4-nitrophenyl)-propylamino]-ethyl}-amide, dihydrochloride salt; antiviral, antineoplastic, anticarcinogenic agents; neoplasms |
| 02/15/2007 | US20070037794 Heteroaryl sulfonamides and CCR2 |
| 02/15/2007 | US20070037785 Novel dipeptidyl peptidase IV inhibitors used for functionally influencing different cells and treating immunological, infammatory, neuronal, and other diseases |
| 02/15/2007 | US20070037606 Transmitter of wireless microphone, receiver for wireless microphone, portable information communication device, and wireless microphone communication system |
| 02/15/2007 | US20070037012 having an anthracene compound substituted with at least one thiophenyl ring; OLED organic light emitters; as displays with low power consumption, faster response time, higher brightness level, unlimited viewing angle |
| 02/15/2007 | CA2618888A1 Acyltryptophanols for fertility control |
| 02/15/2007 | CA2618481A1 Compounds for treating alzheimer's disease |
| 02/15/2007 | CA2618474A1 Compounds for treating alzheimer's disease |
| 02/15/2007 | CA2618019A1 Compounds for the treatment of alzheimer's disease |
| 02/15/2007 | CA2618013A1 Beta-secretase inhibitors for use in the treatment of alzheimer's disease |
| 02/15/2007 | CA2617225A1 Novel heterocyclic nf-kb inhibitors |
| 02/15/2007 | CA2616428A1 Pyrazine derivatives useful as adenosine receptor antagonists |
| 02/15/2007 | CA2616249A1 A process for the preparation of substituted phenyl ether compounds and rosiglitazone |
| 02/14/2007 | EP1752455A2 Chemokine receptor binding heterocyclic compounds |
| 02/14/2007 | EP1751149A1 Bicyclic-substituted amines having cyclic-substituted monocyclic substituents |
| 02/14/2007 | EP1751148A1 Ziprasidone hydrochloride polymorph and process for its preparation |
| 02/14/2007 | EP1751147A1 New amorphous ziprasidone hydrochloride (5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2h-indol-2-one hydrochloride) and process to produce the same |
| 02/14/2007 | EP1751146A2 Pyridinyl- or pyrimidinyl thiazoles with protein kinase inhibiting activity |
| 02/14/2007 | EP1751143A1 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 02/14/2007 | EP1751131A1 Mtp inhibiting aryl piperidines or piperazines substituted with 5-membered heterocycles |
| 02/14/2007 | EP1751127A2 Novel cylopenta¬b|benzofuran derivatives and the utilization thereof |
| 02/14/2007 | EP1751116A2 Pyrimidine compounds and use thereof |
| 02/14/2007 | EP1751113A1 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 02/14/2007 | EP1750704A2 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 02/14/2007 | EP1750698A2 5-anilino-4-heteroarylpyrazole derivatives useful for the treatment of diabetes |
| 02/14/2007 | EP1668005B1 Acyloxymethylcarbamate prodrugs of oxazolidinones |
| 02/14/2007 | EP1651640B1 Nicotinamide derivatives useful as pde4 inhibitors |
| 02/14/2007 | EP1628662B1 Benzothiazole derivatives and use thereof in the treatment of diseases related to the adenosine a2a receptor |
| 02/14/2007 | EP1345928B1 Pyrazole compounds useful as protein kinase inhibitors |
| 02/14/2007 | EP1339701B1 Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors |
| 02/14/2007 | EP1299378B1 Tetrahydropyridino or piperidino heterocyclic derivatives |
| 02/14/2007 | EP1294715B1 Quinazoline ditosylate salt compounds |
| 02/14/2007 | CN1914225A HCV NS-3 serine protease inhibitors |
| 02/14/2007 | CN1914224A HCV NS-3 serine protease inhibitors |
| 02/14/2007 | CN1914209A Diaza- or thiazadione derivatives with neuroprotective activity |
| 02/14/2007 | CN1914199A Pyridinyl - or pyrimidinyl thiazoles with protein kinase inhibiting activity |
| 02/14/2007 | CN1914179A Immobilized n-substituted tricyclic 3-aminopyrazoles for the identification of biomolecular targets |
| 02/14/2007 | CN1914170A Synthetic methodology for the reductive alkylation at the c-3 position of indoles |
| 02/14/2007 | CN1913895A Novel M3 muscarinic acetylcholine receptor antagonists |
| 02/14/2007 | CN1913886A 杂环天冬氨酰蛋白酶抑制剂 Heterocyclic aspartyl protease inhibitors |
| 02/14/2007 | CN1913884A Substituted benzazoles and methods of their use as inhibitors of RAF kinase |
| 02/14/2007 | CN1911918A Kappa-opioid receptor agonist composed of 2-phenylbenzothiazoline derivative |
| 02/14/2007 | CN1300114C Phenylpyridine carbonyl piperazine derivative |